SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-20-010693
Filing Date
2020-12-28
Accepted
2020-12-28 13:00:09
Documents
1
Group Members
ANDREW J. M. SPOKESDAVID T. KIMFARALLON CAPITAL (AM) INVESTORS, L.P.FARALLON CAPITAL F5 MASTER I, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CA

Document Format Files

Seq Description Document Type Size
1 g1221200sc13g.htm SC 13G 329685
  Complete submission text file 0001214659-20-010693.txt   332258
Mailing Address C/O FARALLON CAPITAL MANAGEMENT, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address C/O FARALLON CAPITAL MANAGEMENT, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 4154212132
Zone II Healthcare Holdings, LLC (Filed by) CIK: 0001820598 (see all company filings)

IRS No.: 844819517 | State of Incorp.: NY
Type: SC 13G

Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Subject) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91930 | Film No.: 201417120
SIC: 2836 Biological Products, (No Diagnostic Substances)